OS THERAPIES INCORPORATED (OSTX) Operating income 2023–2025
OS THERAPIES INCORPORATED (OSTX) annual operating income history from SEC filings — each fiscal year as reported.
-$28.7MFY2025 · since FY2023: -$4.3M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.7M | -321.3% |
| FY2024 | -$6.8M | -56.9% |
| FY2023 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OSTX financial trends
OSTX RevenueOSTX Net incomeOSTX Net marginOSTX Gross profitOSTX Gross marginOSTX Operating marginOSTX Operating cash flowOSTX Free cash flowOSTX Capital expendituresOSTX Return on equityOSTX Stock buybacksOSTX Dividends paidOSTX Total assetsOSTX Total liabilitiesOSTX Shareholders’ equityOSTX overview →